chronic pain
Emerging Technologies
Dave Rosa, president and CEO of NeuroOne, joins MobihealthNews for Part 2 of the Emerging Technologies series to discuss the company's thin-film electrode technology.
The company will use the funds to advance product innovation, strengthen clinical partnerships and accelerate its nationwide growth.
Former Zuellig Pharma exec Louis Payet launches Peach Health Asia, aiming to make coach-guided tele-physiotherapy and digital rehabilitation accessible across Southeast Asia.
It has shown potential to significantly reduce pain intensity.
Emotional regulation could be the missing piece of the chronic pain treatment puzzle, says Australian researchers.
The company will use the funds to accelerate the development of its Ellipse Spinal Cord Stimulator Platform, used to treat chronic pain.
The award will support veterans' access to the California-based virtual reality company's FDA-authorized at-home chronic low back pain offering, RelieVRx.
The digital therapeutics company and virtual chronic pain-management program will combine their offerings to create a digital care-management solution for chronic pain.
The study was supported by AppliedVR and used its system for treating chronic lower-back pain. The tool received FDA De Novo clearance last year.
Cofounder and CEO Matthew Stoudt discusses AppliedVR's De Novo clearance from November, what's next for the company and the biggest trends from 2021.